PDLIM2 and neoplasm: The results demonstrated significantly higher numbers of CD14+ and CD68+ cells in the tumour infiltrate of PDLIM2-positive tumours and in PDLIM2-positive stroma than in either PDLIM2-negative tumours or stroma (Figures 2A–C).